Video: Dr. Amy Krambeck performs HoLEP

As the year comes to a close, we revisit some of this year’s top content on benign prostatic hyperplasia in urology.

The data were presented at the recent American Urological Association Annual Meeting.

The center will offer a comprehensive range of treatments, including prostate artery embolization for men suffering from benign prostatic hyperplasia with very large prostates.

“Even though there [are] many therapies that one can do, it's not a sign of anything ominous for most men,” says Kevin T. McVary, MD, FACS.

The research projects are assessing combination therapies in advanced prostate cancer that include the use of relugolix.

Support for the NICE recommendation included 5-year results from the WATER trial, which showed that Aquablation had strong efficacy and safety vs transurethral resection of the prostate in patients with BPH.